Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

39.00
Delayed Data
As of Sep 22
 -0.40 / -1.02%
Today’s Change
17.25
Today|||52-Week Range
50.05
+54.46%
Year-to-Date

Today’s Trading

Previous close39.40
Today’s open39.35
Day’s range38.80 - 39.63
Volume670,853
Average volume (3 months)733,474
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-40.62%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+48.87%
P/E ratio19.5
Price/Sales6.07
Price/Book10.16

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-1.17-7.41%
PRTAProthena Corporation...-0.29-0.45%
IRWDIronwood Pharmaceuti...+0.32+2.06%
HZNPHorizon Pharma PLC+0.05+0.41%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.27
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts